Skip to main content
BioPlus Co., Ltd logo

BioPlus Co., Ltd — Investor Relations & Filings

Ticker · 099430 ISIN · KR7099430001 KO Manufacturing
Open in API
Filings indexed 226 across all filing types
Latest filing 2026-02-13 Notice of Dividend Amou…
Country KR South Korea
Listing KO 099430

About BioPlus Co., Ltd

https://ubioplus.com/

BioPlus Co., Ltd. is a company that researches, develops, and manufactures biomaterials, with a primary focus on hyaluronic acid (HA) applications. The company's core competency is its proprietary MDM® Technology, which is used to create a diverse product portfolio for the beauty and healthcare industries. Key products include a range of dermal and body fillers, skin boosters, anti-adhesion agents, biomaterial breast implants, and artificial cartilage. The company aims to provide bio-therapy solutions by addressing fundamental cellular-level issues through its advanced technologies.

Recent filings

Filing Released Lang Actions
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from '바이오플러스' (Bioplus) regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the expected date of the general meeting for approval. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2026-02-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure of personal share transactions by company directors and executives, which corresponds to the 'Director's Dealing' category.
2026-02-04 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from a Korean company (Bioplus) detailing the acquisition of convertible bonds before maturity (Call Option exercise). This type of corporate action regarding debt instruments and capital structure changes falls under the 'Capital/Financing Update' category, as it specifically addresses the company's financing activities and debt management.
2026-02-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of a director (Jung Hyun Kyu) of BioPlus Co., Ltd. due to market purchases. This is a standard regulatory filing for insider trading/director dealings, which corresponds to the 'Director's Dealing' category.
2026-01-26 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details a change in shareholding percentage (from 5.03% to 3.98%) by Korea Securities Finance Corp in BioPlus Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks changes in significant ownership levels.
2026-01-08 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서(약식)' which translates to 'Report on Large Shareholding Status (Abbreviated)'. It contains detailed information about shareholding changes, including dates, share quantities, ownership percentages, and reasons for changes. The document references specific legal provisions related to capital markets and financial investment laws, indicating it is a regulatory filing about share ownership. There is no indication that this is an annual report, earnings release, or any other financial report. The content matches the description of a Major Shareholding Notification, which reports changes in significant share ownership levels. The document length is over 6,000 characters and contains substantive data, so it is not a mere announcement or certification. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2025-10-10 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.